Literature DB >> 9333051

Pharmacodynamic effects of antibiotics and acid pump inhibitors on Helicobacter pylori.

M Sörberg1, H Hanberger, M Nilsson, L E Nilsson.   

Abstract

Pharmacodynamic studies of Helicobacter pylori exposed to amoxicillin, clarithromycin, metronidazole, omeprazole, and lansoprazole were performed with microscopy, viable count determination, and bioluminescence assay of intracellular ATP. The pharmacodynamic parameters determined were change in morphology, change in cell density, postantibiotic effect (PAE), and control-related effective regrowth time (CERT). The PAE is delayed regrowth after brief exposure to antibiotics or acid pump inhibitors. CERT was defined as the time required for the bacteria to resume logarithmic growth and return to the pre-exposure inoculum in the test culture minus the corresponding time for the control culture. CERT measures the combined effect of initial killing and PAE. There was a good concordance between the bioluminescence assay and viable counts for determining CERT, which makes this parameter useful for pharmacodynamic studies of the effects of antibiotics and acid pump inhibitors on H. pylori. Amoxicillin and metronidazole produced a strong, concentration-dependent initial decrease in CFU per milliliter, but there was a less prominent initial change in intracellular ATP in these cultures. Amoxicillin caused a long PAE when assayed by the bioluminescence assay but no PAE or a negative PAE when assayed by viable count determination. However, amoxicillin showed similar long CERTs with both methods. The pharmacodynamic effects of amoxicillin were concentration dependent up to a maximum response, indicating that concentrations above this level do not increase the antibiotic effect. The PAEs and CERTs of clarithromycin and metronidazole were concentration dependent with no maximum response. With omeprazole and lanzoprazole, there was no PAE or CERT.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9333051      PMCID: PMC164096     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  30 in total

1.  Survival of Helicobacter pylori in water and saline.

Authors:  A P West; M R Millar; D S Tompkins
Journal:  J Clin Pathol       Date:  1990-07       Impact factor: 3.411

2.  Evaluation of acridine orange stain for detection of microorganisms in blood cultures.

Authors:  L R McCarthy; J E Senne
Journal:  J Clin Microbiol       Date:  1980-03       Impact factor: 5.948

3.  Postantibiotic effect of meropenem on members of the family Enterobacteriaceae determined by five methods.

Authors:  F M MacKenzie; I M Gould; D G Chapman; D Jason
Journal:  Antimicrob Agents Chemother       Date:  1994-11       Impact factor: 5.191

4.  Frequencies of variants resistant to different aminoglycosides in Pseudomonas aeruginosa.

Authors:  L Nilsson; L Sörén; G Rådberg
Journal:  J Antimicrob Chemother       Date:  1987-08       Impact factor: 5.790

5.  Pharmacodynamic effects of antibiotics and antibiotic combinations on growing and nongrowing Staphylococcus epidermidis cells.

Authors:  E Svensson; H Hanberger; L E Nilsson
Journal:  Antimicrob Agents Chemother       Date:  1997-01       Impact factor: 5.191

6.  Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: the MACH I Study.

Authors:  T Lind; S Veldhuyzen van Zanten; P Unge; R Spiller; E Bayerdörffer; C O'Morain; K D Bardhan; M Bradette; N Chiba; M Wrangstadh; C Cederberg; J P Idström
Journal:  Helicobacter       Date:  1996-09       Impact factor: 5.753

7.  Control-related effective regrowth time and post-antibiotic effect of meropenem on gram-negative bacteria studied by bioluminescence and viable counts.

Authors:  H Hanberger; E Svensson; L E Nilsson; M Nilsson
Journal:  J Antimicrob Chemother       Date:  1995-05       Impact factor: 5.790

8.  Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer.

Authors:  E Hentschel; G Brandstätter; B Dragosics; A M Hirschl; H Nemec; K Schütze; M Taufer; H Wurzer
Journal:  N Engl J Med       Date:  1993-02-04       Impact factor: 91.245

9.  Response of Campylobacter pyloridis to antibiotics, bismuth and an acid-reducing agent in vitro--an ultrastructural study.

Authors:  J A Armstrong; S H Wee; C S Goodwin; D H Wilson
Journal:  J Med Microbiol       Date:  1987-12       Impact factor: 2.472

10.  Bactericidal and morphological effects of amoxicillin on Helicobacter pylori.

Authors:  V Berry; K Jennings; G Woodnutt
Journal:  Antimicrob Agents Chemother       Date:  1995-08       Impact factor: 5.191

View more
  8 in total

1.  Pharmacodynamic effects of nitroimidazoles alone and in combination with clarithromycin on Helicobacter pylori.

Authors:  Margareta Svensson; Lennart E Nilsson; Magnus Ström; Maud Nilsson; Mikael Sörberg
Journal:  Antimicrob Agents Chemother       Date:  2002-07       Impact factor: 5.191

2.  Risk of development of in vitro resistance to amoxicillin, clarithromycin, and metronidazole in Helicobacter pylori.

Authors:  M Sörberg; H Hanberger; M Nilsson; A Björkman; L E Nilsson
Journal:  Antimicrob Agents Chemother       Date:  1998-05       Impact factor: 5.191

3.  In Vitro and In Vivo Antibacterial Activities of Patchouli Alcohol, a Naturally Occurring Tricyclic Sesquiterpene, against Helicobacter pylori Infection.

Authors:  Y F Xu; D W Lian; Y Q Chen; Y F Cai; Y F Zheng; P L Fan; W K Ren; L J Fu; Y C Li; J H Xie; H Y Cao; B Tan; Z R Su; P Huang
Journal:  Antimicrob Agents Chemother       Date:  2017-05-24       Impact factor: 5.191

4.  In vitro pharmacodynamic studies of activities of ketolides HMR 3647 (Telithromycin) and HMR 3004 against extracellular or intracellular Helicobacter pylori.

Authors:  I Gustafsson; L Engstrand; O Cars
Journal:  Antimicrob Agents Chemother       Date:  2001-01       Impact factor: 5.191

Review 5.  Pharmacokinetics of antibacterial agents in the CSF of children and adolescents.

Authors:  Amanda K Sullins; Susan M Abdel-Rahman
Journal:  Paediatr Drugs       Date:  2013-04       Impact factor: 3.022

6.  In vitro antibacterial activity of acyl-lysyl oligomers against Helicobacter pylori.

Authors:  Morris O Makobongo; Tchelet Kovachi; Hanan Gancz; Amram Mor; D Scott Merrell
Journal:  Antimicrob Agents Chemother       Date:  2009-07-20       Impact factor: 5.191

Review 7.  Treatment of Helicobacter pylori infection: current status and future concepts.

Authors:  Jyh-Chin Yang; Chien-Wei Lu; Chun-Jung Lin
Journal:  World J Gastroenterol       Date:  2014-05-14       Impact factor: 5.742

8.  Toxin-Antitoxin Systems - A New Player in Morphological Transformation of Antibiotic-Exposed Helicobacter pylori?

Authors:  Paweł Krzyżek
Journal:  Front Cell Infect Microbiol       Date:  2021-04-26       Impact factor: 5.293

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.